Improved endpoints for cancer immunotherapy trials.

Axel Hoos; Alexander M M Eggermont; Sylvia Janetzki; F Stephen Hodi; Ramy Ibrahim; Aparna Anderson; Rachel Humphrey; Brent Blumenstein; Lloyd Old; Jedd Wolchok

doi:10.1093/jnci/djq310

Improved endpoints for cancer immunotherapy trials.

Identifier:nobleid.org/w1/20260515/DFE2F57C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFE2F57C.svg?ark=w1%2F20260515%2FDFE2F57C)](https://nobleid.org/work/w1/20260515/DFE2F57C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Axel Hoos

Alexander M M Eggermont

Claim authorship of this work

Improved endpoints for cancer immunotherapy trials.

Identifier:nobleid.org/w1/20260515/DFE2F57C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFE2F57C.svg?ark=w1%2F20260515%2FDFE2F57C)](https://nobleid.org/work/w1/20260515/DFE2F57C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Axel Hoos

Alexander M M Eggermont

Claim authorship of this work